Around the World's Markets: London
IN ANOTHER day of heavy trading, blue chips edged ahead, ignoring a poor opening in New York. The prospect of more corporate activity and even lower interest rates helped Footsie to an 11.2-point gain to 6,264.1; supporting indices also moved ahead.
Hopes of more bid action on the drugs front lifted SmithKline Beecham 36.5p to 892p and Zeneca, as its merger with Sweden's Astra was being sealed, jumped 110p to 2,945p, a peak.
Derek Pain, page 17
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies